Applicability of the MASK-Air(®) App to Severe Asthma Treated with Biologic Molecules: A Pilot Study

MASK-air(®), a good practice of the DG Santé, has been fully validated in allergic rhinitis, but little is known about its applicability to asthmatics. We explored whether the MASK-air(®) application is applicable to patients with severe asthma. Severe asthmatics were proposed to use the MASK-air(®)...

Descripción completa

Detalles Bibliográficos
Autores principales: Benfante, Alida, Sousa-Pinto, Bernardo, Pillitteri, Gianluca, Battaglia, Salvatore, Fonseca, Joao, Bousquet, Jean, Scichilone, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569460/
https://www.ncbi.nlm.nih.gov/pubmed/36232771
http://dx.doi.org/10.3390/ijms231911470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569460/
https://www.ncbi.nlm.nih.gov/pubmed/36232771
http://dx.doi.org/10.3390/ijms231911470

Ejemplares similares